Your Source for Venture Capital and Private Equity Financings

Select An Article

Vigil Neuroscience Completes $90M Series B
2021-08-18
CAMBRIDGE, MA, Vigil Neuroscience, a biotechnology company announced the completion of a $90 million Series B financing led by Vida Ventures.
Read More
OSARO Raises $30M Series C Round
2021-08-18
SAN FRANCISCO, CA, OSARO, a developer of robotic automation for logistics, has completed a Series C funding round led by Octave Ventures.
Read More
TurnoverBnB Scores $4.5M in Series A Round
2021-08-18
HONOLULU, HI, TurnoverBnB, a SaaS platform for vacation rental services, announced the completion of a $4.5-million Series A raise.
Read More
Prieto Battery Snares $5.7M in Series C
2021-08-18
FORT COLLINS, CO, Prieto Battery has closed on the first tranche of its $5.7 million Series C Round financing, led by Pilatus Capital.
Read More
One Announces $40M in Series B
2021-08-18
SACRAMENTO, CA, Financial technology company, One, announced its Series B funding of $40 million, led by Progressive Investment Company.
Read More
LitPic Raises $1.5M in Venture Capital
2021-08-18
SEATTLE, WA, LitPic, a social network, has raised $1.5M in venture capital.
Read More
Enable Bags $45M Series B
2021-08-18
SAN FRANCISCO, CA, Enable, a B2B rebate management platform, closes $45M in Series B financing, led by Norwest Venture Partners.
Read More
WeSpire Receives $13M in Series B Funding
2021-08-18
BOSTON, MA, WeSpire, an employee experience platform for ESG initiatives, has secured $13M in a Series B funding led by Level Structured Capital.
Read More
Aiera Lands Strategic Capital
2021-08-18
NEW YORK, NY, Aiera is announcing the close of a strategic round.
Read More
TrustLayer Lands $15M Series A Funding
2021-08-18
SAN FRANCISCO, CA, Trustlayer, an insurance company, announced a Series A funding round of $15.1M led by Craft Ventures.
Read More
Rapid Robotics Collects $36.7M in Series B
2021-08-18
SAN FRANCISCO, CA, Rapid Robotics announced $36.7M in Series B funding led by Kleiner Perkins and Tiger Global.
Read More
Immunitas Therapeutics Scores $58M Series B
2021-08-18
WALTHAM, MA, Immunitas Therapeutics, a biotechnology company, announced $58M in a Series B funding led by Agent Capital.
Read More